HMGB1: a common biomarker and potential target for TBI, neuroinflammation, epilepsy, and cognitive dysfunction YN Paudel, MF Shaikh, A Chakraborti, Y Kumari, Á Aledo-Serrano, ... Frontiers in neuroscience 12, 628, 2018 | 246 | 2018 |
Impact of HMGB1, RAGE, and TLR4 in Alzheimer’s disease (AD): from risk factors to therapeutic targeting YN Paudel, E Angelopoulou, C Piperi, I Othman, K Aamir, MF Shaikh Cells 9 (2), 383, 2020 | 174 | 2020 |
Revisiting the role of neurotransmitters in epilepsy: An updated review E Akyuz, AK Polat, E Eroglu, I Kullu, E Angelopoulou, YN Paudel Life sciences 265, 118826, 2021 | 156 | 2021 |
Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling YN Paudel, E Angelopoulou, C Piperi, VRMT Balasubramaniam, ... European journal of pharmacology 858, 172487, 2019 | 153 | 2019 |
Role of inflammation in epilepsy and neurobehavioral comorbidities: Implication for therapy YN Paudel, MF Shaikh, S Shah, Y Kumari, I Othman European journal of pharmacology 837, 145-155, 2018 | 126 | 2018 |
miR-124 and Parkinson’s disease: A biomarker with therapeutic potential E Angelopoulou, YN Paudel, C Piperi Pharmacological Research 150, 104515, 2019 | 102 | 2019 |
High mobility group box 1 (HMGB 1) as a novel frontier in epileptogenesis: from pathogenesis to therapeutic approaches YN Paudel, BD Semple, NC Jones, I Othman, MF Shaikh Journal of neurochemistry 151 (5), 542-557, 2019 | 76 | 2019 |
Emerging neuroprotective effect of metformin in Parkinson’s disease: A molecular crosstalk YN Paudel, E Angelopoulou, C Piperi, MF Shaikh, I Othman Pharmacological research 152, 104593, 2020 | 73 | 2020 |
HMGB1-mediated neuroinflammatory responses in brain injuries: potential mechanisms and therapeutic opportunities YN Paudel, E Angelopoulou, C Piperi, I Othman, MF Shaikh International Journal of Molecular Sciences 21 (13), 4609, 2020 | 67 | 2020 |
Potential neuroprotective effect of the HMGB1 inhibitor glycyrrhizin in neurological disorders YN Paudel, E Angelopoulou, B Semple, C Piperi, I Othman, MF Shaikh ACS chemical neuroscience 11 (4), 485-500, 2020 | 67 | 2020 |
APOE genotype and Alzheimer’s disease: the influence of lifestyle and environmental factors E Angelopoulou, YN Paudel, SG Papageorgiou, C Piperi ACS chemical neuroscience 12 (15), 2749-2764, 2021 | 54 | 2021 |
Environmental impact on the epigenetic mechanisms underlying Parkinson’s disease pathogenesis: a narrative review E Angelopoulou, YN Paudel, SG Papageorgiou, C Piperi Brain Sciences 12 (2), 175, 2022 | 48 | 2022 |
Neuroprotective potential of cinnamon and its metabolites in Parkinson's disease: Mechanistic insights, limitations, and novel therapeutic opportunities E Angelopoulou, YN Paudel, C Piperi, A Mishra Journal of biochemical and molecular toxicology 35 (4), e22720, 2021 | 45 | 2021 |
Fractalkine (CX3CL1) signaling and neuroinflammation in Parkinson’s disease: Potential clinical and therapeutic implications E Angelopoulou, YN Paudel, MF Shaikh, C Piperi Pharmacological research 158, 104930, 2020 | 45 | 2020 |
Embelin prevents seizure and associated cognitive impairments in a pentylenetetrazole-induced kindling zebrafish model UP Kundap, YN Paudel, Y Kumari, I Othman, MF Shaikh Frontiers in pharmacology 10, 315, 2019 | 43 | 2019 |
Neuroprotective potential of chrysin: Mechanistic insights and therapeutic potential for neurological disorders A Mishra, PS Mishra, R Bandopadhyay, N Khurana, E Angelopoulou, ... Molecules 26 (21), 6456, 2021 | 39 | 2021 |
Enlightening the neuroprotective effect of quercetin in epilepsy: From mechanism to therapeutic opportunities E Akyuz, YN Paudel, AK Polat, HE Dundar, E Angelopoulou Epilepsy & Behavior 115, 107701, 2021 | 38 | 2021 |
Emerging role of S100B protein implication in Parkinson’s disease pathogenesis E Angelopoulou, YN Paudel, C Piperi Cellular and Molecular Life Sciences 78, 1445-1453, 2021 | 37 | 2021 |
Role of innate immune receptor TLR4 and its endogenous ligands in epileptogenesis YN Paudel, E Angelopoulou, E Akyuz, C Piperi, I Othman, MF Shaikh Pharmacological research 160, 105172, 2020 | 33 | 2020 |
The possible hormetic effects of fluorene-9-bisphenol on regulating hypothalamic-pituitary-thyroid axis in zebrafish M Jin, J Dang, YN Paudel, X Wang, B Wang, L Wang, P Li, C Sun, K Liu Science of the Total Environment 776, 145963, 2021 | 32 | 2021 |